Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AGEN

Agenus (AGEN)

Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AGEN
DateTimeSourceHeadlineSymbolCompany
02/19/20144:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
02/19/20144:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
02/19/20144:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
02/19/20144:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
02/19/20144:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
02/14/20144:49PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AGENAgenus Inc
02/14/20144:29PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AGENAgenus Inc
02/14/20146:04AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AGENAgenus Inc
02/13/20147:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGENAgenus Inc
02/13/20147:00AMBusiness WireAgenus Completes Acquisition of 4-AntibodyNASDAQ:AGENAgenus Inc
02/10/201410:01AMBusiness WireAgenus Announces Closing of Public Offering and Exercise of Over-Allotment OptionNASDAQ:AGENAgenus Inc
02/07/20142:15PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AGENAgenus Inc
02/07/201411:41AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AGENAgenus Inc
02/06/20141:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGENAgenus Inc
02/06/20148:00AMBusiness WireAgenus to Present at BIO CEO & Investor ConferenceNASDAQ:AGENAgenus Inc
02/06/20146:03AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AGENAgenus Inc
02/05/20144:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
02/05/20149:31AMBusiness WireAgenus Prices Public Offering of Common StockNASDAQ:AGENAgenus Inc
02/04/20145:05PMBusiness WireAgenus Announces Public Offering of Common StockNASDAQ:AGENAgenus Inc
02/04/20144:42PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AGENAgenus Inc
02/04/20144:28PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGENAgenus Inc
01/21/20149:00AMBusiness WireAgenus’ Prophage Vaccine for Glioma Hailed As a ‘Very Promising Therapy’ in an Editorial Published in the Journal Neuro...NASDAQ:AGENAgenus Inc
01/14/20147:00AMBusiness WireAgenus Announces Phase 2 Checkpoint inhibitor Combination Trial with Prophage Cancer Vaccine for MelanomaNASDAQ:AGENAgenus Inc
01/13/20147:00AMBusiness WireAgenus Enters into Definitive Agreement to Acquire Privately Held 4-Antibody AGNASDAQ:AGENAgenus Inc
01/13/20147:00AMBusiness WireAgenus Appoints Robert B. Stein, MD, PhD, as Chief Scientific OfficerNASDAQ:AGENAgenus Inc
01/08/20144:45PMBusiness WireAgenus to Present at OneMedForum San Francisco 2014NASDAQ:AGENAgenus Inc
12/18/20137:00AMInvestorsHub NewsWireUnbiased In-Depth Research Reports for (Nasdaq: AGEN), (OTC: ENRT), (OTC: ELRA) and (OTC: NVOB)NASDAQ:AGENAgenus Inc
12/17/20139:04AMZacksAgenus (AGEN) Soars: Stock Adds 12.7% in Session - Tale of the TapeNASDAQ:AGENAgenus Inc
12/16/20137:00AMBusiness WirePositive Phase 2 Results from Agenus’ Brain Cancer Vaccine Published in Neuro-OncologyNASDAQ:AGENAgenus Inc
11/18/20137:00AMBusiness WireAgenus’ Brain Cancer Vaccine Program Named a "Top Project to Watch" by Elsevier Business IntelligenceNASDAQ:AGENAgenus Inc
 Showing the most relevant articles for your search:NASDAQ:AGEN